Ironwood Pharma (IRWD) Misses Q1 EPS by 22c ; Offers Guidance

Ironwood Pharma (NASDAQ: IRWD) reported Q1 EPS of ($0.02), $0.22 worse than the analyst estimate of $0.20. Revenue for the quarter came in at $47.87 million versus the consensus estimate of $105.7 million.

GUIDANCE:

Ironwood Pharma sees FY2024 revenue of $405-425 million, versus the consensus of $447.8 million.

For earnings history and earnings-related data on Ironwood Pharma (IRWD) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Worried the AI trade has gone too far? Evercore likes these 4 stocks
• AXT appoints Tracy Liu to its board of directors